Chromadex, The Potential "Game Changer" In Patient Dependency Of The Multi-Billion Dollar Pharmaceutical Industry
Dr. Nalini Rajamannan of Sacred Heart Cardiology, Chicago IL, notes that Chromadex offers a very important aspect in the field of approaching hypertension and hyperlipidemia in patients who are at risk or who have these disease processes.
"Basic science and future clinical trials in treating patients will provide critical information for these products to try and slow the progression of heart disease," said Rajamannan."
SOURCE Rob Amaefule's Office
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV